MDCO

The Medicines Company Press Releases

$24.43
*  
0.20
0.81%
Get MDCO Alerts
*Delayed - data as of Jul. 25, 2014  -  Find a broker to begin trading MDCO now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

The Medicines Company Reports Second Quarter and First Half 2014 Results
7/23/2014 7:00:00 AM - Business Wire

The Medicines Company to Announce Second Quarter and First Half 2014 Financial Results on Wednesday, July 23, 2014
7/9/2014 10:00:00 AM - Business Wire

The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission
7/7/2014 9:00:00 AM - Business Wire

Health Care Sector Equities Coverage -- Research on Johnson and Johnson, Medicines Co., Merck, and Novo Nordisk
6/13/2014 7:40:00 AM - PR Newswire

ORBACTIVTM (Oritavancin) Phase 3 Trial Results Published in New England Journal of Medicine
6/5/2014 6:00:00 AM - Business Wire

The Medicines Company to Participate in Goldman Sachs 35th Annual Global Healthcare Conference
6/4/2014 4:21:00 PM - Business Wire

The Medicines Company Presents Seven Hospital Data Analyses at Leading Health Economics and Outcomes Research Conferences
6/4/2014 8:35:00 AM - Business Wire

The Medicines Company to Participate in 2014 Jefferies Global Healthcare Conference
5/27/2014 3:54:00 PM - Business Wire

Data on Angiox (Bivalirudin Injection) in Heart Attack Patients Presented at EuroPCR and Published in European Heart Journal
5/22/2014 7:00:00 AM - Business Wire

Technical Coverage on Pharma Equities -- Research on Allergan, Actavis, Medicines Co., and Akorn
5/9/2014 11:30:00 AM - PR Newswire

The Medicines Company to Host Surgery and Perioperative Care Investor and Analyst Meeting on May 22
5/8/2014 12:09:00 PM - Business Wire

The Medicines Company to Participate in 2014 Bank of America Global Healthcare Conference
5/6/2014 1:58:00 PM - Business Wire

The Medicines Company and Alnylam Announce Presentation of New Pre-Clinical Data on PCSK9 at Arteriosclerosis, Thrombosis and Vascular Biology 2014 Scientific Sessions
5/1/2014 11:02:00 AM - Market Wire

The Medicines Company Receives Complete Response Letter From FDA Requesting Additional Information for New Drug Application for Its Antiplatelet Agent Cangrelor
4/30/2014 7:42:00 PM - Market Wire